Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by John Araujo
A Phase 2 Trial of Sunitinib in Patients With Advanced Non–clear Cell Renal Cell Carcinoma
European Urology
Urology
Related publications
Safety and Efficacy of Sunitinib for Advanced Non-Clear Cell Renal Cell Carcinoma
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial
Oncologist
Cancer Research
Medicine
Oncology
Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma
Current Oncology
Oncology
Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Phase III Trial of Adjuvant Sunitinib in Patients With High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis
Clinical Cancer Research
Cancer Research
Oncology
A Phase I, Open-Label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Sphingosine Kinase 1 Overexpression Contributes to Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
OncoImmunology
Oncology
Allergy
Immunology
A Phase II Trial of Sunitinib in Patients With Renal Cell Cancer and Untreated Brain Metastases
Clinical Genitourinary Cancer
Oncology
Urology
Prognostic Value of Granulocyte Colony-Stimulating Factor in Patients With Non-Metastatic Clear Cell Renal Cell Carcinoma
Oncotarget
Oncology
